Table 2.
Comparison of baseline characteristics between the sufentanil and butorphanol groups
|
|
Sufentanil group (n = 55)
|
Butorphanol group (n = 55)
|
P value
|
| Age | 71.0 ± 5.7 | 69.6 ± 5.7 | 0.199 |
| Gender (male/female) | 32/23 | 34/21 | 0.698 |
| ASA (I/II/III) | 0/33/22 | 0/30/25 | 0.847 |
| Weight (kg) | 63.6 ± 10.3 | 68.6 ± 11.3 | 0.058 |
| BMI (kg/m2) | 21.1 ± 1.8 | 20.81 ± 1.7 | 0.403 |
| Smoking (yes/no) | 25/30 | 26/29 | 0.703 |
| PONV or motion sickness history (yes/no) | 14/41 | 20/35 | 0.218 |
| Operation time (h) | 3.41 ± 1.30 | 3.25 ± 1.07 | 0.484 |
| Intraoperative infusion volume (mL) | 1290.9 ± 404.7 | 1243.6 ± 316.8 | 0.497 |
| Postoperative 24-h infusion volume (mL) | 2380.9 ± 137.6 | 2342.7 ± 133.8 | 0.143 |
| Postoperative 48-h infusion volume (mL) | 2152.7 ± 128.9 | 2125.5 ± 117.4 | 0.249 |
ASA: American Society of Anesthesiologists; BMI: Body mass index; PONV: Postoperative nausea and vomiting.